Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Erlotinib can cause hair loss as a side effect.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Some herbal extracts can promote hair growth and prevent hair loss.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Gefitinib can cause rare scarring hair loss.

Increasing miR-149 reduces hair follicle stem cell growth and hair development by affecting certain cell growth pathways.

Certain cancer drugs can cause skin issues like rashes and itching.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

MG53 helps reduce skin damage caused by nitrogen mustard.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

A new compound shows promise as a topical treatment for hair loss.

Applying a specific inhibitor lightens skin and hair color.